Blog
Why does ‘Feelings Data’ matter to us?
We live in a world in which “feelings” symptoms carry far less gravitas than those that are physical. Though physical traits will always be paramount in disease tracking and treatment, we have realised that acknowledging how patients feel is just as important. Why is...
Feelings data – why collect it?
Personalised medicine is about getting patients on the right medicine, at the right time on the right dose. Many factors play into achieving this, none more so than patient involvement in their treatment plan – sharing their opinions and feelings at different stages...
Talking Medicines : Driving more Effective Medicines By Listening to Patient
Founders Jo Halliday, CEO and Elizabeth Fairley, COO of Talking Medicines recently collaborated with a US pharma trade publication based out of New York called pharma's almanac. The article published articulates their views on the opportunities for marketing in pharma...
The term ‘stroke’ being classed as a health condition & symptom
Of interest to us, health conditions are defined differently by patients and doctors. One example that we have come across recently in our annotation data, is the description of the term ‘stroke’. A stroke as we are all aware is a life-threatening event that happens...
How we can help fight the global cardiovascular health crisis
Cardiovascular diseases are the number one cause of death globally (CDC). CVD takes an estimated 17.9 million lives each year and accounts for a quarter of all deaths in the states and the UK (BHF). There are many medical risk factors that can contribute to...
The impact of coronavirus on ethnic minorities
Over the last few months we have seen an alarming number of deaths in ethnic minority groups due to coronavirus. In fact, the figures show that the death rate for Black and Asian people is four and three times greater respectively than for White people (Public Health...
How have we been lending a hand to the COVID-19 effort?
COVID-19 is undoubtedly having an impact on patient populations. During this challenging time, Talking Medicines have been doing their bit to support the Medsmart® community whilst sharing data insight from greater patient populations to add value to Government data,...
Week 9 of government advised lockdown: COVID-19 survey update
Talking Medicines have now captured 1,827 responses across five surveys showing the public opinions to COVID-19. Outreach engagement is via direct Facebook from the Medsmart® community to understand the attitudes, views and behaviour changes in the community towards...
COVID-19 – Why the gender disparity?
Over the last few weeks there has been a lot of speculation over what exacerbates an individual’s response to coronavirus and why there is such great disparity in the gender of those dying from this virus. One explanation being explored is the effect of Angiotensin...